NUAK2

NUAK family kinase 2, the group of NUAK family kinases

Basic information

Region (hg38): 1:205302063-205321745

Links

ENSG00000163545NCBI:81788OMIM:608131HGNC:29558Uniprot:Q9H093AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • anencephaly 2 (Limited), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Anencephaly 2ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Neurologic; Ophthalmologic32845958

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NUAK2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NUAK2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
1
clinvar
3
missense
50
clinvar
3
clinvar
53
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 50 5 1

Variants in NUAK2

This is a list of pathogenic ClinVar variants found in the NUAK2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-205303469-A-C not specified Uncertain significance (Feb 21, 2024)3202682
1-205303484-C-T not specified Uncertain significance (Jan 18, 2025)3881457
1-205303493-G-A not specified Uncertain significance (Dec 10, 2024)3408343
1-205303537-C-G not specified Uncertain significance (Apr 09, 2024)3301329
1-205303550-C-T not specified Uncertain significance (Nov 15, 2024)3408342
1-205303551-G-C not specified Uncertain significance (Sep 28, 2022)2366225
1-205303604-G-A not specified Likely benign (Dec 14, 2021)2355290
1-205303610-T-C not specified Uncertain significance (Feb 28, 2024)3202681
1-205303632-G-A not specified Uncertain significance (Jan 27, 2025)3881458
1-205303664-T-A not specified Uncertain significance (Feb 13, 2024)3202680
1-205303685-G-A not specified Uncertain significance (Jul 09, 2024)3408339
1-205303724-C-T not specified Uncertain significance (Aug 08, 2023)2617560
1-205303733-C-T not specified Likely benign (Dec 22, 2024)3881461
1-205303746-G-A not specified Uncertain significance (Dec 31, 2024)3881459
1-205303754-G-T not specified Uncertain significance (Dec 14, 2024)3202679
1-205303791-C-T not specified Likely benign (Oct 03, 2022)2374409
1-205303802-G-A not specified Uncertain significance (May 04, 2023)2516828
1-205303821-C-T not specified Uncertain significance (Feb 10, 2022)2347956
1-205303871-G-A not specified Uncertain significance (Aug 14, 2024)3408341
1-205303872-G-A not specified Uncertain significance (Jan 21, 2025)3881466
1-205303912-G-A Benign (Mar 01, 2024)2639850
1-205303913-C-A not specified Uncertain significance (Jan 23, 2025)3881462
1-205303922-A-G not specified Uncertain significance (May 20, 2024)3301325
1-205303948-G-A Likely benign (Dec 01, 2022)2639851
1-205303974-G-A not specified Uncertain significance (Jul 09, 2024)3408338

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NUAK2protein_codingprotein_codingENST00000367157 719697
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00004990.9931257080401257480.000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.183243900.8310.00002354060
Missense in Polyphen119160.930.739431824
Synonymous0.3681551610.9630.000009261310
Loss of Function2.401123.60.4660.00000133259

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003480.000335
Ashkenazi Jewish0.000.00
East Asian0.0002720.000272
Finnish0.000.00
European (Non-Finnish)0.0001960.000193
Middle Eastern0.0002720.000272
South Asian0.0002610.000163
Other0.0001650.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Stress-activated kinase involved in tolerance to glucose starvation. Induces cell-cell detachment by increasing F-actin conversion to G-actin. Expression is induced by CD95 or TNF-alpha, via NF-kappa-B. Protects cells from CD95-mediated apoptosis and is required for the increased motility and invasiveness of CD95- activated tumor cells. Able to phosphorylate 'Ser-464' of LATS1. {ECO:0000269|PubMed:14575707, ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15345718, ECO:0000269|PubMed:19927127}.;

Recessive Scores

pRec
0.120

Intolerance Scores

loftool
0.508
rvis_EVS
-0.66
rvis_percentile_EVS
16.02

Haploinsufficiency Scores

pHI
0.114
hipred
N
hipred_score
0.351
ghis
0.515

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.973

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Nuak2
Phenotype
homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; pigmentation phenotype; embryo phenotype;

Gene ontology

Biological process
protein phosphorylation;apoptotic process;actin cytoskeleton organization;intracellular signal transduction;cellular response to glucose starvation;negative regulation of apoptotic process
Cellular component
nucleus;cytoplasm
Molecular function
magnesium ion binding;protein serine/threonine kinase activity;protein binding;ATP binding